Bereich
Infektiologie | Infektionsprävention | Reisemedizin
INFEKT · Dept. I
Clinical relevance of cytomegalovirus viraemia(*,†)
El Amari E, Hirschel B, Bernasconi E, Hirsch H, Vernazza P, Cavassini M, Furrer H, Hasse B, Kaiser L, Calmy A, Yerly S, Combescure C, Swiss HIV Cohort Study. Clinical relevance of cytomegalovirus viraemia(*,†). HIV Med 2011; 12:394-402.
19.01.2011Clinical relevance of cytomegalovirus viraemia(*,†)
19.01.2011HIV Med 2011; 12:394-402
El Amari E Boffi, Hirschel B, Bernasconi E, Hirsch Hh, Vernazza Pietro, Cavassini M, Furrer H, Hasse B, Kaiser L, Calmy A, Yerly S, Combescure C, Swiss HIV Cohort Study
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Ortiz M, Tarr P, Telenti A, Günthard H, Ledergerber B, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Elzi L, Arnedo M, Martinez R, Kovari H, Furrer H, Poloni E, Swiss HIV Cohort Study. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 2011; 203:620-4.
12.01.2011No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
12.01.2011J Infect Dis 2011; 203:620-4
Ortiz Millán, Tarr Philip E, Telenti Amalio, Günthard Huldrych F, Ledergerber Bruno, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Bernasconi Enos, Elzi Luigia, Arnedo Mireia, Martinez Raquel, Kovari Helen, Furrer Hansjakob, Poloni Estella S, Swiss HIV Cohort Study
Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
Kouyos R, Cavassini M, Rauch A, Battegay M, Vernazza P, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard H, Hirschel B, Weber R, Klimkait T, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, Taffé P, Shah C, Bürgisser P, Swiss HIV Cohort Study. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 2011; 52:532-9.
10.01.2011Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection
10.01.2011Clin Infect Dis 2011; 52:532-9
Kouyos Roger D, Cavassini Matthias, Rauch Andri, Battegay Manuel, Vernazza Pietro, Bernasconi Enos, Ledergerber Bruno, Bonhoeffer Sebastian, Günthard Huldrych F, Hirschel Bernard, Weber Rainer, Klimkait Thomas, von Wyl Viktor, Yerly Sabine, Böni Jürg, Rieder Philip, Joos Beda, Taffé Patrick, Shah Cyril, Bürgisser Philippe, Swiss HIV Cohort Study
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
Gianella S, Günthard H, Joos B, Weber R, Vernazza P, Hirschel B, Rauch A, Cavassini M, Bernasconi E, Battegay M, Niederoest B, Fischer M, von Wyl V, the Swiss HIV Cohort Study. Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA. Antivir Ther 2011; 16:535-545.
01.01.2011Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
01.01.2011Antivir Ther 2011; 16:535-545
Gianella Sara, Günthard Huldrych F, Joos Beda, Weber Rainer, Vernazza Pietro, Hirschel Bernard, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Niederoest Barbara, Fischer Marek, von Wyl Viktor, the Swiss HIV Cohort Study
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Lubomirov R, Telenti A, Günthard H, Furrer H, Vernazza P, Elzi L, Bernasconi E, Hirschel B, Cavassini M, Martinez R, Ledergerber B, di Iulio J, Colombo S, the Swiss HIV Cohort Study. Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study. J Infect Dis 2010; 203:246-257.
09.12.2010Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
09.12.2010J Infect Dis 2010; 203:246-257
Lubomirov Rubin, Telenti Amalio, Günthard Huldrych F, Furrer Hansjakob, Vernazza Pietro, Elzi Luigia, Bernasconi Enos, Hirschel Bernard, Cavassini Matthias, Martinez Raquel, Ledergerber Bruno, di Iulio Julia, Colombo Sara, the Swiss HIV Cohort Study
Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Magenta L, Bernasconi E, Bucher H, Decosterd L, Cavassini M, Evison J, Vernazza P, Hirschel B, Flepp M, Hasse B, Young J, Richter W, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS). Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses 2010
22.11.2010Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
22.11.2010AIDS Res Hum Retroviruses 2010
Magenta L, Bernasconi E, Bucher H C, Decosterd L A, Cavassini M, Evison J, Vernazza Pietro, Hirschel B, Flepp M, Hasse B, Young J, Richter W O, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS)
HIV-Infektion – Früherkennung verhindert Folgeschäden für Individuum und Gesellschaft
Bertisch B. HIV-Infektion – Früherkennung verhindert Folgeschäden für Individuum und Gesellschaft. Swiss Medical Forum 2010; 10:798-801.
17.11.2010HIV-Infektion – Früherkennung verhindert Folgeschäden für Individuum und Gesellschaft
17.11.2010Swiss Medical Forum 2010; 10:798-801
Bertisch Barbara
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Rotger M, Tarr P, Telenti A, Egger M, Ledergerber B, Weber R, Furrer H, Hirschel B, Bernasconi E, Cavassini M, Vernazza P, Elzi L, Taffé P, Martinez R, Gsponer T, Swiss HIV Cohort Study. Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clin Infect Dis 2010; 51:1090-8.
01.11.2010Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
01.11.2010Clin Infect Dis 2010; 51:1090-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Egger Matthias, Ledergerber Bruno, Weber Rainer, Furrer Hansjakob, Hirschel Bernard, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Elzi Luigia, Taffé Patrick, Martinez Raquel, Gsponer Thomas, Swiss HIV Cohort Study
Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Nicca D, Bernasconi E, Cavassini M, Elzi L, Evison J, Jeannin A, Glass T, Vernazza P, Hirschel B, Ledergerber B, Swiss HIV Cohort Study. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2010; 51:1314-22.
29.10.2010Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study
29.10.2010Clin Infect Dis 2010; 51:1314-22
Hasse Barbara, Weber Rainer, Nicca Dunja, Bernasconi Enos, Cavassini Matthias, Elzi Luigia, Evison John-Marc, Jeannin Andre, Glass Tracy R, Vernazza Pietro, Hirschel Bernard, Ledergerber Bruno, Swiss HIV Cohort Study
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Young J, Bucher H, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Cavassini M, Fux C, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard H, Scherrer A, for the Swiss HIV Cohort Study. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010
18.10.2010Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
18.10.2010HIV Med 2010
Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza P, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*). HIV Med 2010
18.10.2010Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study(*)
18.10.2010HIV Med 2010
Ledergerber B, Weber R, Rickenbach M, Furrer H, Hirschel B, Vernazza Pietro, Bernasconi E, Battegay M, Cavassini M, and the Swiss HIV Cohort Study (SHCS)
B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering
Audigé A, Schlaepfer E, von Wyl V, Miller R, Vernazza P, Nadal D, Speck R, SHCS. B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering. AIDS Res Hum Retroviruses 2010; 26:1063-74.
01.10.2010B cells from HIV-infected patients with primary central nervous system lymphoma display an activated phenotype and have a blunted TNF-? response to TLR9 triggering
01.10.2010AIDS Res Hum Retroviruses 2010; 26:1063-74
Audigé Annette, Schlaepfer Erika, von Wyl Viktor, Miller Regina C, Vernazza Pietro, Nadal David, Speck Roberto F, SHCS
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
Alizon S, Bonhoeffer S, Günthard H, Telenti A, Bürgisser P, Battegay M, Bernasconi E, Vernazza P, Rauch A, Furrer H, Klimkait T, Shah C, Böni J, Hirschel B, Yerly S, Kouyos R, Stadler T, von Wyl V, Swiss HIV Cohort Study. Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS Pathog 2010; 6
30.09.2010Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load
30.09.2010PLoS Pathog 2010; 6
Alizon Samuel, Bonhoeffer Sebastian, Günthard Huldrych F, Telenti Amalio, Bürgisser Philippe, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Rauch Andri, Furrer Hansjakob, Klimkait Thomas, Shah Cyril, Böni Jürg, Hirschel Bernard, Yerly Sabine, Kouyos Roger D, Stadler Tanja, von Wyl Viktor, Swiss HIV Cohort Study
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
Gutmann C, Vernazza P, Yerly S, Cavassini M, Decosterd L, Hirschel B, Fux C, Günthard H, Cusini A, Swiss HIV Cohort Study (SHCS). Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir. AIDS 2010; 24:2347-54.
24.09.2010Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
24.09.2010AIDS 2010; 24:2347-54
Gutmann Christine, Vernazza Pietro, Yerly Sabine, Cavassini Matthias, Decosterd Laurent-Arthur, Hirschel Bernard, Fux Christoph, Günthard Huldrych F, Cusini Alexia, Swiss HIV Cohort Study (SHCS)
Low Postseroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV(+) Fast Progressors
Audigé A, Taffé P, Rickenbach M, Battegay M, Vernazza P, Nadal D, Speck R. Low Postseroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV(+) Fast Progressors. AIDS Res Hum Retroviruses 2010; 26:997-1005.
01.09.2010Low Postseroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV(+) Fast Progressors
01.09.2010AIDS Res Hum Retroviruses 2010; 26:997-1005
Audigé Annette, Taffé Patrick, Rickenbach Martin, Battegay Manuel, Vernazza Pietro, Nadal David, Speck Roberto F
Porträt einer 1-jährigen Pandemie: "Schwein gehabt"?
Schlegel M, Hoffmann M. Porträt einer 1-jährigen Pandemie: "Schwein gehabt"?. Swiss Medical Forum 2010; 10:540-544.
18.08.2010Porträt einer 1-jährigen Pandemie: "Schwein gehabt"?
18.08.2010Swiss Medical Forum 2010; 10:540-544
Schlegel Matthias, Hoffmann Matthias
Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study
Thurnheer M, Furrer H, Zwahlen M, Christen A, Bernasconi E, Schmid P, Elzi L, Cavassini M, Toutous-Trellu L, Weber R, Swiss HIV Cohort Study. Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS 2010; 24:1907-16.
31.07.2010Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study
31.07.2010AIDS 2010; 24:1907-16
Thurnheer Maria Christine, Furrer Hansjakob, Zwahlen Marcel, Christen Anna B, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Toutous-Trellu Laurence, Weber Rainer, Swiss HIV Cohort Study
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
Rohrbach J, Rauch A, Klenerman P, Furrer H, Battegay M, Bernasconi E, Hoffmann M, Hirschel B, Günthard H, Keiser O, Telenti A, Gorgievski M, Gaudieri S, Hammond E, Harcourt G, Robinson N, Swiss HIV Cohort Study S. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut 2010; 59:1252-1258.
26.07.2010Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy
26.07.2010Gut 2010; 59:1252-1258
Rohrbach Janine, Rauch Andri, Klenerman Paul, Furrer Hansjakob, Battegay Manuel, Bernasconi Enos, Hoffmann Matthias, Hirschel Bernhard, Günthard Huldrych F, Keiser Olivia, Telenti Amalio, Gorgievski Meri, Gaudieri Silvana, Hammond Emma, Harcourt Gillian, Robinson Nicola, Swiss HIV Cohort Study SHCS
Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland
Bertisch B, Vernazza P, Boggian K. Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland. Swiss Med Wkly 2010; 140:w13069.
15.07.2010Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland
15.07.2010Swiss Med Wkly 2010; 140:w13069
Bertisch Barbara, Vernazza Pietro, Boggian Katia
Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient
Hoffmann M, Tsinalis D, Vernazza P, Fierz W, Binet F. Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Med Wkly 2010; 140:286-92.
24.05.2010Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient
24.05.2010Swiss Med Wkly 2010; 140:286-92
Hoffmann Matthias, Tsinalis Dimitrios, Vernazza Pietro, Fierz W, Binet Françoise-Isabelle